Download presentation
1
Management of Infants requiring Venovenous ECMO
Sixto F. Guiang, III Dept. of Pediatrics University of Minnesota
2
Neonatal ECMO = 73 % of all ECMO
VV ECMO = 20% of all Neonatal Pulmonary
3
University of Michigan
JAMA 2000;283: N= 1000 Newborns N=586 Survival 88% MAS 98% CDH 68% Others % 90% veno-venous 9% IVH
4
VV ECMO Respiratory Mode for all ages
Infants 20% of all Respiratory ECMO Approximately 800 cases / yr Pediatric 28% of all Respiratory ECMO Approximately 200 cases / yr
5
Pediatric VV ECMO Pediatr Crit Care Med 2003;4:291-298
Single Center N = 82 ECMO for Respiratory Failure Venovenous 83% Venoarterial 17% Unable to place VV 43%
6
Pediatric VV ECMO Venovenous Dx ARDS RSV bronchiolitis Penumonia
Outcomes Lower degree of respiratory failure Shorter ECMO (212 hour vs 350 hours) Higher survival (81% vs. 64%)
7
Pediatric VV ECMO Pediatr Crit Care Med 2003;4:
8
Infusion limb Drainage limb
9
Inclusion / Exclusion Guidelines- Same as VA
age of at least 34 weeks Weight > kg Potentially reversible process Absence of uncorrectable cardiac defect Absence of major intracranial hemorrhage Absence of uncorrectable coagulopathy Absence of lethal anomaly Absence of prolonged mechanical ventilation with high ventilatory settings
10
Oxygenation Failure Criteria - VA and VV
Alveolar - arterial oxygen tension gradient [ )-paCO2] - paO2 torr for greater than 4-12 hours Oxygenation index Mean Airway Pressure x FiO2 x 100/ paO2 > for greater than 1-6 hours
11
Oxygenation Failure Criteria - VA and VV
paO2 PaO2 < 35 for 2 hours paO2 < 50 for 12 hours Acute decompensation paO2 < 30 torr
12
Myocardial Failure - VA Only
Refractory hypotension Low cardiac output pH <7.25 for 2 hours or greater Uncontrolled metabolic acidosis secondary to hemodynamic insufficiency Cardiac arrest - CPR
13
Additional Exclusion Criteria - Venovenous ECMO
Severe LV dysfunction Severe hypotension Cannulation during CPR Desire to not have heparin Bleeding
14
Additional Exclusion Criteria - Venovenous ECMO
Use of vasopressors is NOT a contraindication for VV ECMO Isolated RV failure is NOT a contraindication for VV ECMO
15
Vasopresor - VV ECMO ASAIO Journal 2003;49:568-571
Neonatal ECMO-VA and VV N = 43 Quantified inotropic support - Index 1 point = 1mcg/kgmin Dopamine Dobutamine 1 point = 0.01 mcg/kg/mon Epinephrine Norepinephrine
16
ASAIO Journal 2003;49:
17
ASAIO Journal 2003;49:
18
ASAIO Journal 2003;49:
19
Infants with Inotropic Score > 10
ASAIO Journal 2003;49:
20
ECMO Goals - VA and VV Maintain adequate tissue oxygenation to allow recovery from short term cardiopulmonary failure Adjust ventilator settings allowing for Lung Rest minimizing further ventilator /oxygen induced lung injury. Not necessarily lower settings
21
ECMO Modes Venoarterial - VA Blood drains-venous system
Blood returns-arterial system Complete cardiopulmonary support Venovenous - VV Blood returns-venous system Pulmonary support only
22
Advantages of VA ECMO Able to give full cardiopulmonary support
No mixing of arterial / venous blood Good oxygenation at low ECMO flows Allows for total lung rest
23
Disadvantages of VA ECMO
Ligation of the right carotid artery Nonpulsatile arterial blood flow Suboptimal conditions for LV function Low preload High afterload High wall stress Low coronary oxygenation
24
Disadvantages of VA ECMO
Systemic emboli Air thrombus
25
Advantages of VV ECMO No ligation of carotid artery
Normal pulsatile blood flow Optimize LV performance More preload Less afterload Better coronary oxygenation Less ventricular wall stress No systemic emboli
26
Disadvantages of VV ECMO
Need a functioning LV Mixing of blood lower arterial saturation Need increased ECMO flow Need higher hemoglobin Need to place a larger cannula More difficulty monitoring adequacy of oxygen delivery Recirculation of ECMO flow
27
Disadvantages of VV ECMO
May need to convert to VA Need to be fully heparinized Cannula cannot be heparin bonded
28
VV ECMO -Double lumen Newborns >90% of VV ECMO - Double lumen
12F and 15F OriGen Pediatric 35% of VV ECMO -double lumen 18F - largest OriGen cannula 65% internal jugular, femoral, sapphenous
29
VV ECMO -Double lumen Cannula site
Internal jugular vein (15F double lumen- preferred) Cannula tip low in the right atrium
31
Drainage Infusion High lateral RA Mid Medial RA Low lateral RA Endhole
34
Optimal Cannula Placement
Adequate size Correct depth Low Right Atrium Correct Rotation Label visible Drainage limb (Blue) posterior Infusion limb (Red) anterior Vertical orientation Head - midline No Kinks
36
Recirculation Oxygenated ECMO blood returning to the ECMO circuit immediately after infusion
37
Recirculation factors
Head /cannula position Changes with head rotation Changes in lung volume / relative position of the heart and cannula ECMO flow Right atrial size / intravascular volume RV contractility
38
ECMO blood flow to baby - 160 ECMO Flow reads 200
39
ECMO blood flow to baby - 250 ECMO Flow reads 500
40
ECMO Flow -Recirculation
More ECMO flow will always increase recirculation More ECMO flow may either Increase blood flow to baby Decrease blood flow to baby
41
VA ECMO ECMO flow rate is proportional to the level of support
More flow More support Always advantageous if more flow is possible More ECMO flow will always increase SvO2
42
Pulmonary Support - VV Net ECMO blood flow of infant = measure ECMO flow - recirculation flow ECMO flow (flow probe) DOES NOT indicate level of support SvO2 DOES NOT reflect level of systemic oxygen delivery
43
Circulatory Support Net flow to baby assessed by Infant color
Infant arterial saturation and PaO2
44
Assessment of Recirculation
More recirculation if Decreasing baby arterial sat or PaO2 Increasing SvO2 on ECMO circuit Decreasing color difference on drainage and infusion limbs of circuit
45
Reducing Recirculation
Adjusting relative cannula position Head position Lung inflation Decrease ECMO flow Increase intravascular volume Increase RV contractility Volume Vasopressors Pulmonary vasodilators
46
VV - VA Conversion Needed if 10-15% of cases
Hemodynamic support is inadequate Respiratory support is inadequate More problematic when ultrafiltration is used
47
VV ECMO - Specific Issues
ECMO Prime Must have added heparin Must have Ca added Ionized Ca on circuit must be checked prior to cannulation Potassium must be checked
48
Heparin If no heparin added
Addition of Ca binds citrate of blood products Loss of anticoagulant activity Acute clotting of the entire circuit Need to prime another circuit
49
Calcium If no calcium added
Acute hypocalcemia - Ca binds to citrate of blood products Loss of LV and RV contractility Acute hypotension Cardiac arrest
50
Potasium If potassium in prime is not checked
Possible higher serum K from the stored PRBC Acute hyperkalemia Arrythmia Cardiac arrest
51
Head / Cannula Position
Distal tip low in RA Head in the midline with vertical orientation of the drainage and infusion limbs RA drainage ports Lateral Infusion ports Medial
52
Keys to Management VV ECMO- DL
Need to think in terms of NET blood flow to the baby Cannot quantify NET flow SvO2 is not indicative of adequacy of systemic oxygen delivery Indirectly assessed with SaO2 and PaO2 on the infant
53
To Improve oxygenation
Give PRBC Increase ECMO flow Decrease recirculation Check cannula position Increase ntravascular volume Increase RV contractility
54
Rest Ventilator Settings
Pressures - similar to VA FiO2 - able to wean to RA frequently Better myocardial oxygenation via ECMO flow than VA
55
Jugular venous drainage
11% of all double lumen VV Small study suggested decrease IVH Reduced cerebral venous pressure Advantage Additional drainage facilities flow 2 site venous drainage lessens recirculation on VV ECMO Improved oxygen delivery Enables venous oxygen saturation monitoring on VV ECMO
56
Jugular Venous Drainage Cephalad Cannula
J Pediatr Surg 2004;39: Review of ELSO database Neonatal Respiratory Failure VV ECMO N = 2471 96% VV double lumem alone 3.7% with jugular venous drainage Similar Outcomes
57
Operating Parameters SaO2 - 85-95% PaO2 40-65 torr
Blood pressure - similar to VA ECMO flows ml/kg/min HgB g/dl
58
Weaning of ECMO - VV No clamp out needed Increase ventilator
Decrease sweep gas flow rate and FiO2 Sweep gas flow can be completely stopped SvO2 will reflect mixed venous saturation No recirculation
59
Gas Flow
60
NO Gas Flow
61
VV ECMO Outcomes Generally slightly better than VA, but slightly different patient populations Hemodynamically more stable Less exposure to CPR Better survival Shorter duration of ECMO Conversion VV to VA 12%
62
VA - VV Comparison studies
J Peds Surg1993;28: Multicenter data N=243 VA = 135 VV = 108 Similar survival 10% conversion to VA Shorter runs Less Neurologic complications
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.